LIMBER UniLeg: Rapid, On-demand, and Scaled-up Manufacturing of Customized Transtibial Prosthetic Legs for Amputees

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorLIMBER Prosthetics & Orthotics Inc

About this trial

The LIMBER UniLeg, a 3D printed single-piece transtibial prosthetic limb, is sufficiently equivalent to traditional passive prosthetic limbs (no motors or sensors), while reducing the cost and time of manufacturing and enabling global reach through the use of digital technologies to solve the worldwide prosthetic accessibility crisis. This is a single-site, Phase I, Clinical Research Study to test the effectiveness and safety of the LIMBER UniLeg. One study group of 30 participants involved for two months using a non-inferiority design in which the participant will be assessed using their normal device (1 month) and the study device (1 month).

Eligibility criteria

Qualifiers

Provision of signed and dated informed consent form.

Stated willingness to comply with all study procedures and availability for the duration of the study.

Persons, aged 18 to 75

In good general health as determined by clinical site monitor

Disqualifiers

Not currently using a prosthetic device

Prosthetic device with active motors, sensors, etc.

Pregnancy (due to fall risk)

Diabetic (due to poor limb sensation), self reported

Trial design

Treatments tested in this trial

  • Limber Limb

Treatment groups

30 Participants
are divided into 1 treatment group

Sponsors and collaborators

LIMBER Prosthetics & Orthotics Inc

Lead sponsor

University of California, San Diego

Collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborator